Moderna, Inc. (MRNA)
NASDAQ: MRNA · IEX Real-Time Price · USD
110.59
+3.18 (2.96%)
At close: Mar 27, 2024, 4:00 PM
110.80
+0.21 (0.19%)
Pre-market: Mar 28, 2024, 8:40 AM EDT
Moderna Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Moderna stock have an average target of 132.58, with a low estimate of 86 and a high estimate of 231. The average target predicts an increase of 19.88% from the current stock price of 110.59.
Analyst Consensus: Hold
* Price targets were last updated on Feb 26, 2024.
Analyst Ratings
The average analyst rating for Moderna stock from 16 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 3 | 3 | 3 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 8 | 9 | 9 | 9 | 7 | 8 |
Sell | 2 | 2 | 2 | 2 | 2 | 2 |
Strong Sell | 0 | 1 | 1 | 1 | 1 | 1 |
Total | 16 | 18 | 18 | 17 | 15 | 16 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 28, 2024 |
HSBC | HSBC | Hold → Sell Downgrades $75 → $86 | Hold → Sell | Downgrades | $75 → $86 | -22.24% | Feb 26, 2024 |
RBC Capital | RBC Capital | Buy Reiterates $125 | Buy | Reiterates | $125 | +13.03% | Feb 23, 2024 |
Canaccord Genuity | Canaccord Genuity | Hold Maintains $82 → $91 | Hold | Maintains | $82 → $91 | -17.71% | Feb 23, 2024 |
RBC Capital | RBC Capital | Buy Reiterates $125 | Buy | Reiterates | $125 | +13.03% | Jan 12, 2024 |
Financial Forecast
Revenue This Year
4.32B
from 6.85B
Decreased by -36.92%
Revenue Next Year
4.83B
from 4.32B
Increased by 11.78%
EPS This Year
-7.24
from -12.33
EPS Next Year
-5.07
from -7.24
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 5.0B | 6.2B | 10.1B | 22.1B | 40.6B |
Avg | 4.3B | 4.8B | 6.5B | 9.9B | 16.9B |
Low | 3.6B | 3.2B | 3.4B | 3.4B | 6.8B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -27.4% | 42.9% | 109.5% | 242.6% | 311.3% |
Avg | -36.9% | 11.8% | 33.9% | 52.7% | 71.6% |
Low | -47.2% | -26.6% | -30.4% | -48.1% | -30.7% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -6.12 | -1.10 | 13.13 | 19.51 | 42.44 |
Avg | -7.24 | -5.07 | -1.05 | 3.80 | 13.39 |
Low | -8.12 | -7.45 | -6.71 | -3.90 | 2.06 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | 1,015.9% |
Avg | - | - | - | - | 252.0% |
Low | - | - | - | - | -45.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.